Source Bioscience PLC Company Profile (LON:SBS)

About Source Bioscience PLC (LON:SBS)

Source Bioscience PLC logoSource BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Ambulance & Emergency Services
  • Sub-Industry: N/A
  • Symbol: LON:SBS
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: GBX 17.81
  • 200 Day Moving Avg: GBX 16.38
  • 52 Week Range: GBX 14 - GBX 19
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Net Margins: 4.60%
  • Return on Equity: 4.26%
  • Return on Assets: 2.84%
  • Average Volume: 338,357 shs.

Frequently Asked Questions for Source Bioscience PLC (LON:SBS)

What is Source Bioscience PLC's stock symbol?

Source Bioscience PLC trades on the London Stock Exchange (LON) under the ticker symbol "SBS."

Who are some of Source Bioscience PLC's key competitors?

How do I buy Source Bioscience PLC stock?

Shares of Source Bioscience PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Source Bioscience PLC's stock price today?

One share of Source Bioscience PLC stock can currently be purchased for approximately GBX 17.50.

MarketBeat Community Rating for Source Bioscience PLC (LON SBS)
Community Ranking:  1.0 out of 5 (star)
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Source Bioscience PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Source Bioscience PLC (LON:SBS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Source Bioscience PLC (LON:SBS)
DateFirmActionRatingPrice TargetDetails
1/29/2016N+1 SingerReiterated RatingcorporateView Rating Details
(Data available from 9/19/2015 forward)


Earnings History for Source Bioscience PLC (LON:SBS)
No earnings announcements for this company have been tracked by


Earnings Estimates for Source Bioscience PLC (LON:SBS)
Current Year EPS Consensus Estimate: $1.00 EPS


Dividend History for Source Bioscience PLC (LON:SBS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Source Bioscience PLC (LON:SBS)
Insider Trades by Quarter for Source Bioscience PLC (LON:SBS)
Insider Trades by Quarter for Source Bioscience PLC (LON:SBS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/14/2015Turnbull,LaurieInsiderSell2,000,000GBX 17£340,000
9/8/2015Ash,Dr NickInsiderSell1,454,243GBX 17£247,221.31
(Data available from 1/1/2013 forward)


Headline Trends for Source Bioscience PLC (LON:SBS)
Latest Headlines for Source Bioscience PLC (LON:SBS)
DateHeadline logoOryx International Growth Fund Net Asset Value Gets Boost From M&A - July 8 at 7:20 PM logoSource BioScience Plc :SBS-GB: Earnings Analysis: For the six months ended December 31, 2015 : August 12, 2016 - April 7 at 12:28 PM logoSource BioScience Agrees GBP62.9 Million Takeover Deal - July 30 at 6:34 PM logoContinental Investment, Harwood To Offer To Buy Source BioScience For 18p/share - June 3 at 7:55 PM logoSource BioScience plc: Final Results - March 22 at 8:42 AM logoOryx International outperforms benchmarks in the first half - November 20 at 8:03 AM logoQuiet day for director dealings - October 14 at 11:53 AM


Social activity is not available for this stock.


Source Bioscience PLC (SBS) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by Staff